In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

Interstitial lung disease is characterized by scarring (fibrosis ... Dr. Yamazaki says, "PET/CT is generally performed to ...

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...

Lung cancer is diagnosed by taking a biopsy from the suspicious area of the lung, which can be done with both bronchoscopy and CT. Imaging tests like CT scans of the lung are done to know about the ...

A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

Medically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Interstitial lung disease is characterized by scarring (fibrosis ... Dr. Yamazaki says "PET/CT is generally performed to ...

DESTINY-Breast06 broke new ground for HER2, moving it one line earlier into chemo-naïve metastatic breast cancer and it showed clear benefit Enhertu ultra-low disease. And Imfinzi is set to begin a ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...